Headspace and Ginger have completed their $3 billion combination to create Headspace Health, a new frontrunner in the The post Headspace and Ginger finalise $3bn digital...
Sanjay Gupta Tucks Tail Back At CNN After Disastrous Rogan Interview Update (1715ET): To the surprise of absolutely nobody, CNN is in major damage control mode...
In this GEN webinar, sponsored by Touchlight, our distinguished presenters Dr. Tommy Duncan and Dr. Jill Makin, will address industry challenges and discuss an alternative to...
AdhereTech, a medtech company based in New York City, has developed the Aidia Smart Bottle (previously known as the Smart Pill Bottle), a connected pill bottle...
Europe's drug regulator started a real-time review of AstraZeneca's antibody-based Covid-19 therapy, the first protective shot other than vaccines against coronavirus.
Joe Rogan Crushes CNN Over Ivermectin 'Horse Paste' Propaganda, Gets Gupta To Concede They Lied Joe Rogan went off big on CNN during an interview with...
Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Right Now? Here’s 3 For Your Watchlist in October appeared...
UK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety The post Digital therapeutics world first for Big...
Health care stocks to consider as stocks seek direction despite positive earnings data. The post 4 Health Care Stocks To Watch As The FDA Talks Booster...
Roche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to The post Actemra shortage spills over to include...
Merck To Double Production Of 'Breakthrough' COVID Drug As Nations Line Up To Buy Despite safety concerns raised by multiple scientists, Merck is signing deals with...
As expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral The post Merck files pill for milder COVID,...
Futures Slide As Soaring Oil Nears $85 While cash bonds may be closed today for Columbus Day, which may or may not be a holiday -...
Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for The post Limbix’ digital therapeutic cuts depression symptoms...
Are these 10 penny stocks on your watch list this week? The post Best Penny Stocks To Buy This Week? 10 With Potential Biotech Catalysts appeared...
David Grainger → In a development that just seemed to add up neatly given Medicxi’s involvement with Centessa, the brainchild of Francesco de Rubertis has named...
Clinical-stage biotechnology company Applied Genetic Technologies (AGTC) is focused on developing genetic therapies for treating rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases....
The National Institutes of Health (NIH) has awarded two Gladstone scientists with NIH Director’s Awards, prestigious grants designed to support innovative, high-risk, high-reward biomedical research projects....
While praising the FDA’s quick, agile and frequent use of the emergency use pathway to authorize Covid-19 tests, drugs and vaccines, the Senate health committee’s top...
Evolution Devices, a company based in California, created a functional electrical stimulation device to assist people with foot drop to walk more freely. Foot drop is...
A remarkable number of life-threatening diseases manifest more severely in males than in females. One current example is COVID-19 caused by SARS CoV-2. Another example is...
In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and...
These health care stocks could be the booster for your portfolio right now. The post 4 Top Health Care Stocks To Watch After Merck’s COVID-19 Pill...
To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections,...
Fauci Isn't Sure You Can Gather For Xmas, But Is Sure You Must Give Up Your Individual Rights Authored by Thomas Lifson via AmericanThinker.com, The highest...
Merck & Company (MRK) gained over 8% to close at $81.40 on October 1. Merck is a biopharmaceutical firm whose main product is the PD-L1 inhibitor...
Welcome to TDR’s review of the Top 5 Psychedelic developments for the week of September 27. Aside from presenting a synopsis of events, we provide market...
Do these biotech stocks have huge upside potential? The post 4 Top Biotech Stocks To Watch In October 2021 appeared first on Stock Market News, Quotes,...
Merck said data from the Phase III MOVe-OUT trial showed that 28 of 385 patients (7.3%) who received molnupiravir were either hospitalized or died through Day...
The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed...